AAT Bioquest Inc.
Pleasanton, CA
- UEI
- D5FRACU48P34
- CAGE
- 4GUG2
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 5775 W Las Positas Blvd #100, Pleasanton, CA 94588, USA
- Website
- aatbio.com
- Founded
- 2006
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $161,032 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A photostable fluorescent probe for imaging live cells alternative to quantum DOT | National Institutes of Health | $100,000 |
Similar vendors
About the company
AAT Bioquest, Inc. is a minority-owned, woman-owned small business registered to receive awards from the U.S. federal government since July 24, 2006. The company is classified as a Corporate Entity (Not Tax Exempt) and is recognized as an Asian-Pacific American Owned business and a manufacturer of goods. AAT Bioquest specializes in providing scientific products and services, particularly in the field of biomedical research and development. Their federal contract awards primarily come from the National Institutes of Health (NIH), specifically the National Center for Advancing Translational Sciences, indicating a focus on products and services that support the acceleration of research translation to improve human health.
The company has been awarded several contracts by the NIH National Center for Advancing Translational Sciences, demonstrating their expertise in providing specialized research materials and services. In May 2024, AAT Bioquest received a firm fixed-price purchase order valued at $161,032.00 for unspecified products or services related to the NIH's mission. In June 2021, they were awarded a $42,840.00 contract for the delivery of 20 units of the Screen Quest Calbryte-520 Probenecid-Free and Wash-Free Calcium Assay Kit, which is likely used in cellular research. Additionally, in August 2019, the company was contracted for $24,800.00 to label RNaseB and streptavidin proteins for an NGLY1 project, showcasing their capabilities in protein labeling and modification. These contracts were all awarded without set-aside designations, indicating that AAT Bioquest successfully competed for these opportunities in the open market.
SBA capabilities narrative
Reagents and assay kits for diagnostics, drug discovery and life sciences
Quick answers
Is AAT Bioquest Inc. registered in SAM.gov?
Yes. AAT Bioquest Inc.'s SAM.gov registration is active through February 9, 2027.
How much has AAT Bioquest Inc. received in federal contracts?
Federal contracts obligated $161,032 to AAT Bioquest Inc. in fiscal years 2023 through 2027.
What is AAT Bioquest Inc.'s most recent federal award?
AAT Bioquest Inc.'s most recent federal contract award is AAT bioquest INC:1186265 [24-001666] (75N95024P00249), from National Institute on Drug Abuse (NIH), on May 1, 2024.
On GovTribe
See AAT Bioquest Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors